A Tricoli, N Nasiri, S De - Advanced Functional Materials, 2017 - Wiley Online Library
The unprecedented medical achievements of the last century have dramatically improved our quality of life. Today, the high cost of many healthcare approaches challenges their long …
I Berindan‐Neagoe, PC Monroig… - CA: a cancer journal …, 2014 - Wiley Online Library
The interplay between abnormalities in genes coding for proteins and noncoding microRNAs (miRNAs) has been among the most exciting yet unexpected discoveries in …
D Sayed, M Abdellatif - Physiological reviews, 2011 - journals.physiology.org
MicroRNAs (miRNAs) are a class of posttranscriptional regulators that have recently introduced an additional level of intricacy to our understanding of gene regulation. There are …
B Xie, Q Ding, H Han, D Wu - Bioinformatics, 2013 - academic.oup.com
Motivation: Research interests in microRNAs have increased rapidly in the past decade. Many studies have showed that microRNAs have close relationships with various human …
Mammalian microRNAs (miRNAs) have recently been identified as important regulators of gene expression, and they function by repressing specific target genes at the post …
T Thum, C Gross, J Fiedler, T Fischer, S Kissler… - Nature, 2008 - nature.com
MicroRNAs comprise a broad class of small non-coding RNAs that control expression of complementary target messenger RNAs,. Dysregulation of microRNAs by several …
YS Lee, A Dutta - Annual Review of Pathology: Mechanisms of …, 2009 - annualreviews.org
Within the past few years, studies on microRNA (miRNA) and cancer have burst onto the scene. Profiling of the miRNome (global miRNA expression levels) has become prevalent …
MP Hunter, N Ismail, X Zhang, BD Aguda, EJ Lee, L Yu… - PloS one, 2008 - journals.plos.org
Background MicroRNAs (miRNA) are small non-coding RNAs that regulate translation of mRNA and protein. Loss or enhanced expression of miRNAs is associated with several …
Acute lymphoblastic leukaemia, a malignant disorder of lymphoid progenitor cells, affects both children and adults, with peak prevalence between the ages of 2 and 5 years. Steady …